No abstract available
Keywords:
Activated protein C resistance; Apixaban; Lupus coagulation inhibitor; Rivaroxaban; Venous thromboembolism.
MeSH terms
-
Administration, Oral
-
Anticoagulants / adverse effects
-
Factor Xa Inhibitors / adverse effects
-
Humans
-
Pyrazoles
-
Pyridones / adverse effects
-
Rivaroxaban / adverse effects
-
Thrombophilia* / drug therapy
-
Venous Thromboembolism* / drug therapy
Substances
-
Anticoagulants
-
Factor Xa Inhibitors
-
Pyrazoles
-
Pyridones
-
apixaban
-
Rivaroxaban